Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOPAlexandar Tzankov, Ken H. Young, Stephan Dirnhofer et al.|Modern Pathology|2013Cited by 129
Clinical and Biological significance of MYC/BCL6 dual gene rearrangements and protein co-expression in de novo diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium ProgramQinng Ye, Ken H. Young, Zijun Y. Xu‐Monette et al.|Clinical Lymphoma Myeloma & Leukemia|2015Cited by 0